U3 Pharma

About:

U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug development.

Top Investors: Atlas Venture, Alta Partners, Edmond de Rothschild Private Equity, LSP BioVentures, BioM Venture Capital

Description:

U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Professor Axel Ullrich. Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.

Total Funding Amount:

$50.8M

Headquarters Location:

Planegg, Bayern, Germany

Founded Date:

2001-01-01

Founders:

Edward Stuart, Tom Geimer

Number of Employees:

11-50

Last Funding Date:

2006-05-22

IPO Status:

Private

Industries: